BMJ Examines Risks of Incretin Therapy

(MedPage Today) -- Incretin mimetics may be more risky than previously thought, given that drug companies have held back data on their potentially harmful effects, says the BMJ.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news